Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2024

Shelley Wood

October 01, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2023

Shelley Wood

July 31, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2020

Shelley Wood

December 31, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Conference News ESC 2020

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

L.A. McKeown

September 03, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

L.A. McKeown

March 28, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

Shelley Wood

March 02, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for September 2024

Scientific Statement Reviews Current Antithrombotic Options in PAD

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

What’s Going to Be Hot at AHA 2023

TCTMD’s Top 10 Most Popular Stories for July 2023

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

TCTMD’s Top 10 Most Popular Stories for November 2022

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

August 2022 News Roundup

TCTMD’s Top 10 Most Popular Stories for June 2022

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

TCTMD’s Top 10 Most Popular Stories for December 2020

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

TCTMD’s Top 10 Most Popular Stories for July 2020

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

TCTMD’s Top 10 Most Popular Stories for February 2020

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content